1. Home
  2. CRMD

as 08-22-2025 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Founded: 2006 Country:
United States
United States
Employees: N/A City: BERKELEY HEIGHTS
Market Cap: 901.8M IPO Year: 2010
Target Price: $16.83 AVG Volume (30 days): 3.4M
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.79 EPS Growth: N/A
52 Week Low/High: $4.87 - $17.43 Next Earning Date: 08-07-2025
Revenue: $121,484,498 Revenue Growth: 14970.29%
Revenue Growth (this year): 278.96% Revenue Growth (next year): 45.85%

CRMD Daily Stock ML Predictions

Share on Social Networks: